Actively Recruiting

Age: 19Years +
All Genders
NCT02138695

The Evaluation for Prognostic Factors After Catheter Ablation of Atrial Fibrillation: Cohort Study

Led by Yonsei University · Updated on 2019-03-18

3100

Participants Needed

1

Research Sites

770 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

1\. Purpose of the study 1\) To explore clinical recurrence associated clinical factors including age, sex, clinical, electrophysiological, anatomical, imaging, and serologic characteristics. 2\) To develop simulation model to predict clinical recurrence and the efficacy of catheter ablation 2. Scientific evidence of the study 1. In atrial fibrillation patients, the maintenance of normal sinus rhythm showed significant reduction of mortality. 2. drug therapy with anti-arrhythmic drug showed many complications and side effect, thus non-drug therapy such as catheter ablation is developed. 3. catheter ablation has been performed for 10years world-wide, and showed superior treatment outcome compared with drug therapy. 4. clinical outcome after catheter ablation is affected not only by age, sex and underlying disease, but also by electrophysiologic, imaging, serologic and electroanatomical remodeling of the heart. However, there are few studies concerning these multifactorial variables. 3\. Study population

CONDITIONS

Official Title

The Evaluation for Prognostic Factors After Catheter Ablation of Atrial Fibrillation: Cohort Study

Who Can Participate

Age: 19Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients undergoing catheter ablation for symptomatic, drug-refractory atrial fibrillation
  • Age 19 years or older
Not Eligible

You will not qualify if you...

  • Patients who do not agree to participate in the study
  • Permanent atrial fibrillation resistant to electrical cardioversion
  • Atrial fibrillation with valvular disease grade 2 or higher
  • Left atrial diameter greater than 60 mm
  • Age less than 19 years

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Severance Hospital

Seoul, South Korea, 120-752

Actively Recruiting

Loading map...

Research Team

H

Hui-Nam Pak, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here